Drugs & Aging

, Volume 28, Issue 7, pp 509–518

Polypharmacy in the Elderly

Can Comprehensive Geriatric Assessment Reduce Inappropriate Medication Use?
  • Giuseppe Sergi
  • Marina De Rui
  • Silvia Sarti
  • Enzo Manzato
Current Opinion

Abstract

Polypharmacy is a problem of growing interest in geriatrics with the increase in drug consumption in recent years, particularly among people aged >65 years. The main reasons for polypharmacy are longer life expectancy, co-morbidity and the implementation of evidence-based clinical practice guidelines. However, polypharmacy also has important negative consequences, such as a higher risk of adverse drug reactions and a decline in medication efficacy because of reduced compliance.

Comprehensive geriatric assessment (CGA) has proved effective in reducing the number of prescriptions and daily drug doses for patients by facilitating discontinuation of unnecessary or inappropriate medications. CGA has also demonstrated an ability to optimize treatment by increasing the number of drugs taken in cases where under-treatment has been identified. Greater multidimensional and multidisciplinary efforts are nonetheless needed to tackle polypharmacy-related problems in frail elderly patients.

CGA should help geriatrics staff identify diseases with higher priority for treatment, thereby achieving better pharmacological treatment overall in elderly patients. The patient’s prognosis should also be considered in the treatment prioritization process.

The most appropriate medication regimen should combine existing evidence-based clinical practice guidelines with data gathered from CGA, including social and economic considerations. Furthermore, for prescriptions to remain appropriate, the elderly should periodically undergo medication review, particularly as the risk or presence of multiple co-morbidities increases.

This article aims to highlight the increasing impact of polypharmacy in the elderly and to underscore the role of CGA in achieving the most appropriate pharmacological treatment in this age group.

References

  1. 1.
    Hovstadius B, Hovstadius K, Astrand B, et al. Increasing polypharmacy: an individual-based study of the Swedish population 2005–2008. BMC Clin Pharmacol 2010; 10: 16PubMedCrossRefGoogle Scholar
  2. 2.
    Haider SI, Johnell K, Thorslund M, et al. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992–2002. Int J Clin Pharmacol Ther 2007 Dec; 45(12): 643–53PubMedGoogle Scholar
  3. 3.
    Marengoni A, Rizzuto D, Wang HX, et al. Patterns of chronic multimorbidity in the elderly population. J Am Geriatr Soc 2009 Feb; 57(2): 225–30PubMedCrossRefGoogle Scholar
  4. 4.
    Franceschi M, Scarcelli C, Niro V, et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 2008; 31(6): 545–56PubMedCrossRefGoogle Scholar
  5. 5.
    Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol 2001 Jun; 51(6): 615–22PubMedCrossRefGoogle Scholar
  6. 6.
    Rubenstein LZ, Josephson KR, Wieland GD, et al. Effectiveness of a geriatric evaluation unit: a randomized clinical trial. N Engl J Med 1984 Dec 27; 311(26): 1664–70PubMedCrossRefGoogle Scholar
  7. 7.
    Stuck AE, Aronow HU, Steiner A, et al. A trial of annual in-home comprehensive geriatric assessments for elderly people living in the community. N Engl J Med 1995 Nov 2; 333(18): 1184–9PubMedCrossRefGoogle Scholar
  8. 8.
    Tulner LR, van Campen JP, Frankfort SV, et al. Changes in under-treatment after comprehensive geriatric assessment: an observational study. Drugs Aging 2010 Oct 1; 27(10): 831–43PubMedCrossRefGoogle Scholar
  9. 9.
    Lampela P, Hartikainen S, Lavikainen P, et al. Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study. Drugs Aging 2010 Jun 1; 27(6): 507–21PubMedCrossRefGoogle Scholar
  10. 10.
    Bjerrum L, Søgaard J, Hallas J, et al. Polypharmacy: correlations with sex, age and drug regimen: a prescription database study. Eur J Clin Pharmacol 1998 May; 54(3): 197–202PubMedCrossRefGoogle Scholar
  11. 11.
    Jyrkkä J, Enlund H, Korhonen MJ, et al. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging 2009; 26(6): 493–503PubMedCrossRefGoogle Scholar
  12. 12.
    Crentsil V, Ricks MO, Xue QL, et al. A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. Am J Geriatr Pharmacother 2010 Jun; 8(3): 215–24PubMedCrossRefGoogle Scholar
  13. 13.
    Harugeri A, Joseph J, Parthasarathi G, et al. Prescribing patterns and predictors of high-level polypharmacy in the elderly population: a prospective surveillance study from two teaching hospitals in India. Am J Geriatr Pharmacother 2010 Jun; 8(3): 271–80PubMedCrossRefGoogle Scholar
  14. 14.
    Dwyer LL, Han B, Woodwell DA, et al. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother 2010 Feb; 8(1): 63–72PubMedCrossRefGoogle Scholar
  15. 15.
    Lapi F, Pozzi C, Mazzaglia G, et al. Epidemiology of sub-optimal prescribing in older, community-dwellers: a two wave, population-based survey in Dicomano, Italy. Drugs Aging 2009; 26(12): 1029–38PubMedCrossRefGoogle Scholar
  16. 16.
    Corsonello A, Pedone C, Corica F, et al. Polypharmacy in elderly patients at discharge from the acute care hospital. Ther Clin Risk Manag 2007 Mar; 3(1): 197–203PubMedCrossRefGoogle Scholar
  17. 17.
    Fillenbaum GG, Horner RD, Hanlon JT, et al. Factors predicting change in prescription and nonprescription drug use in a community-residing black and white elderly population. J Clin Epidemiol 1996 May; 49(5): 587–93PubMedCrossRefGoogle Scholar
  18. 18.
    Tinetti ME, Bogardus Jr ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004 Dec 30; 351(27): 2870–4PubMedCrossRefGoogle Scholar
  19. 19.
    Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005 Aug 10; 294(6): 716–24PubMedCrossRefGoogle Scholar
  20. 20.
    Mansur N, Weiss A, Beloosesky Y. Relationship of in-hospital medication modifications of elderly patients to postdischarge medications, adherence, and mortality. Ann Pharmacother 2008 Jun; 42(6): 783–9PubMedCrossRefGoogle Scholar
  21. 21.
    Viktil KK, Blix HS, Moger TA, et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007 Feb; 63(2): 187–95PubMedCrossRefGoogle Scholar
  22. 22.
    Corsonello A, Pedone C, Corica F, et al. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005 Apr 11; 165(7): 790–5PubMedCrossRefGoogle Scholar
  23. 23.
    Hanlon JT, Pieper CF, Hajjar ER, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 2006 May; 61(5): 511–5PubMedCrossRefGoogle Scholar
  24. 24.
    Field TS, Gurwitz JH, Avorn J, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001 Jul 9; 161(13): 1629–34PubMedCrossRefGoogle Scholar
  25. 25.
    Nguyen JK, Fouts MM, Kotabe SE, et al. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 2006 Mar; 4(1): 36–41PubMedCrossRefGoogle Scholar
  26. 26.
    Gnjidic D, Le Couteur DG, Abernethy DR, et al. Drug Burden Index and Beers Criteria: impact on functional outcomes in older people living in self-care retirement villages. J Clin Pharmacol. Epub 2011 Feb 2Google Scholar
  27. 27.
    Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001 May–Jun; 31(4): 199–205PubMedCrossRefGoogle Scholar
  28. 28.
    Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002 Dec; 50(12): 1962–8PubMedCrossRefGoogle Scholar
  29. 29.
    Malhotra S, Karan RS, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001 Nov; 77(913): 703–7PubMedCrossRefGoogle Scholar
  30. 30.
    Rochon PA, Gurwitz JH. Drug therapy. Lancet 1995 Jul 1; 346(8966): 32–6PubMedCrossRefGoogle Scholar
  31. 31.
    Lai SW, Liao KF, Liao CC, et al. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore) 2010 Sep; 89(5): 295–9CrossRefGoogle Scholar
  32. 32.
    Haleem S, Lutchman L, Mayahi R, et al. Mortality following hip fracture: trends and geographical variations over the last 40 years. Injury 2008 Oct; 39(10): 1157–63PubMedCrossRefGoogle Scholar
  33. 33.
    Ziere G, Dieleman JP, Hofman A, et al. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol 2006 Feb; 61(2): 218–23PubMedCrossRefGoogle Scholar
  34. 34.
    Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001 Aug; 23(8): 1296–310PubMedCrossRefGoogle Scholar
  35. 35.
    Di Bari M, Balzi D, Roberts AT, et al. Prognostic stratification of older persons based on simple administrative data: development and validation of the ‘Silver Code’, to be used in emergency department triage. J Gerontol A Biol Sci Med Sci 2010 Feb; 65(2): 159–64PubMedCrossRefGoogle Scholar
  36. 36.
    Rubenstein LZ, Abrass IB, Kane RL. Improved care for patients on a new geriatric evaluation unit. J Am Geriatr Soc 1981 Nov; 29(11): 531–6PubMedGoogle Scholar
  37. 37.
    Sergi G, Perissinotto E, Pisent C, et al., ILSA Working Group. An adequate threshold for body mass index to detect underweight condition in elderly persons: the Italian Longitudinal Study on Aging (ILSA). J Gerontol A Biol Sci Med Sci 2005 Jul; 60(7): 866–71PubMedCrossRefGoogle Scholar
  38. 38.
    Pilotto A, Ferrucci L, Franceschi M, et al. Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res 2008; 11(1): 151–61PubMedCrossRefGoogle Scholar
  39. 39.
    Pilotto A, Addante F, Ferrucci L, et al. The multidimensional prognostic index predicts short- and long-term mortality in hospitalized geriatric patients with pneumonia. J Gerontol A Biol Sci Med Sci 2009 Aug; 64(8): 880–7PubMedCrossRefGoogle Scholar
  40. 40.
    Pilotto A, Addante F, Franceschi M, et al. Multidimensional Prognostic Index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Heart Fail 2010 Jan; 3(1): 14–20PubMedCrossRefGoogle Scholar
  41. 41.
    Kuijpers MA, van Marum RJ, Egberts AC, et al. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008 Jan; 65(1): 130–3PubMedCrossRefGoogle Scholar
  42. 42.
    Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006 Oct; 54(10): 1516–23PubMedCrossRefGoogle Scholar
  43. 43.
    Rochon PA, Gurwitz JH. Prescribing for seniors: neither too much nor too little. JAMA 1999 Jul 14; 282(2): 113–5PubMedCrossRefGoogle Scholar
  44. 44.
    Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994 Mar 3; 330(9): 592–6PubMedCrossRefGoogle Scholar
  45. 45.
    Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991 Sep; 151(9): 1825–32PubMedCrossRefGoogle Scholar
  46. 46.
    Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts [published erratum appears in Arch Intern Med 2004 Feb 9; 164 (3): 298]. Arch Intern Med 2003 Dec 8–22; 163(22): 2716–24PubMedCrossRefGoogle Scholar
  47. 47.
    Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992 Oct; 45(10): 1045–51PubMedCrossRefGoogle Scholar
  48. 48.
    Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment): Consensus validation. Int J Clin Pharmacol Ther 2008 Feb; 46(2): 72–83PubMedGoogle Scholar
  49. 49.
    George CJ, Jacobs LG. Geriatrics medication management rounds: a novel approach to teaching rational prescribing with the use of the medication screening questionnaire. J Am Geriatr Soc 2011 Jan; 59(1): 138–42. Epub 2011 Jan 3PubMedCrossRefGoogle Scholar
  50. 50.
    Walsh EK, Cussen K. ‘Take ten minutes’: a dedicated ten minute medication review reduces polypharmacy in the elderly. Ir Med J 2010 Sep; 103(8): 236–8PubMedGoogle Scholar
  51. 51.
    Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: how well are states closing the gap? Health Aff (Millwood) 2002 Jul–Dec; Suppl. Web Exclusives: W253–68Google Scholar
  52. 52.
    Doggrell SA. Adherence to medicines in the older-aged with chronic conditions: does intervention by an allied health professional help? Drugs Aging 2010 Mar 1; 27(3): 239–54PubMedCrossRefGoogle Scholar
  53. 53.
    Rich MW, Gray DB, Beckham V, et al. Effect of a multi-disciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 1996 Sep; 101(3): 270–6PubMedCrossRefGoogle Scholar
  54. 54.
    Wu JY, Leung WY, Chang S, et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 2006 Sep 9; 333(7567): 522PubMedCrossRefGoogle Scholar
  55. 55.
    Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006 Mar 27; 166(6): 605–9PubMedCrossRefGoogle Scholar
  56. 56.
    Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007 Jun; 9(6): 430–4PubMedGoogle Scholar
  57. 57.
    Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010 Oct 11; 170(18): 1648–54PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2011

Authors and Affiliations

  • Giuseppe Sergi
    • 1
  • Marina De Rui
    • 1
  • Silvia Sarti
    • 1
  • Enzo Manzato
    • 1
  1. 1.Department of Medical and Surgical Sciences, Geriatrics DivisionUniversity of PadovaPadovaItaly
  2. 2.Clinica Geriatrica-Ospedale Giustinianeo (2o piano)PadovaItaly

Personalised recommendations